Understand Positive Fecal Immunochemical Test (FIT) results, clinical significance, and proper documentation. Learn about FIT test coding, healthcare guidelines, and colorectal cancer screening recommendations. Explore information on false positives, follow-up procedures, and diagnostic colonoscopy. Find resources for healthcare professionals, including medical billing and coding best practices related to a positive FIT result.
Also known as
Other fecal abnormalities
Includes abnormal findings in stool examination.
Encounter for screening for colorectal cancer
Used for encounters specifically for colorectal cancer screening.
Other diseases of intestines
A general category for intestinal issues when a more specific code isn't available.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the positive FIT part of a screening program?
When to use each related code
| Description |
|---|
| Positive FIT |
| Occult blood stool |
| Colorectal cancer |
Coding positive FIT without specifying qualitative or quantitative result can lead to claim denials and inaccurate quality reporting. Impacts CDI and HCC coding.
Positive FIT requires documented follow-up (colonoscopy, etc.). Absent documentation creates audit risk for medical necessity and compliance issues.
Using a diagnostic code when FIT is a screening test leads to overpayment and compliance violations. Ensure proper CPT/ICD-10 coding for screening vs diagnostic.
Patient presents for evaluation of a positive fecal immunochemical test (FIT). The patient reports no overt signs or symptoms of gastrointestinal bleeding such as melena, hematochezia, or abdominal pain. Review of systems is otherwise negative. Past medical history includes hypertension and hyperlipidemia. Family history is significant for colon cancer in a first-degree relative diagnosed at age 65. Surgical history is unremarkable. Medications include lisinopril and atorvastatin. Allergies include penicillin. Physical examination is unremarkable with normal bowel sounds and no abdominal tenderness. Given the positive fecal immunochemical test result, colonoscopy is recommended for colorectal cancer screening and further evaluation of potential sources of bleeding. Patient education was provided regarding the importance of colonoscopy for early detection and prevention of colorectal cancer, as well as potential risks and benefits of the procedure. The patient expressed understanding and agreed to schedule a colonoscopy. Differential diagnosis includes colorectal polyps, colorectal cancer, diverticulosis, and other potential sources of lower gastrointestinal bleeding. ICD-10 code V76.51 (Special screening for malignant neoplasms of the colon) and CPT code 82270 (Fecal occult blood test by immunoassay) are relevant for billing and coding purposes. Follow-up appointment scheduled after colonoscopy procedure for results discussion and further management.